Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets (Unaudited)

v2.4.0.8
Balance Sheets (Unaudited) (USD $)
Dec. 31, 2013
Sep. 30, 2013
CURRENT ASSETS    
Cash $ 4,016,224 $ 5,122,895
Prepaid expenses 19,817 45,350
Total Current Assets 4,036,041 5,168,245
EQUIPMENT, net 26,834 29,755
OTHER ASSETS    
Patent costs, net 526,257 545,865
TOTAL ASSETS 4,589,132 5,743,865
CURRENT LIABILITIES    
Accounts payable and accrued expenses 250,231 465,686
Notes payable    14,051
Total Current Liabilities 250,231 479,737
TOTAL LIABILITIES 250,231 479,737
STOCKHOLDERS' EQUITY    
Preferred stock, Series B; 6,000,000 shares authorized, $0.0001 par value, 0 and 500,000 shares issued and outstanding, respectively    50
Common stock; 180,000,000 shares authorized, $0.0001 par value, 19,970,046 and 19,741,541 shares issued and outstanding, respectively 1,997 1,974
Additional paid-in capital 40,541,713 39,444,988
Accumulated deficit (21,628,748) (21,628,748)
Deficit accumulated during the development stage (14,576,061) (12,554,136)
Total Stockholders' Equity 4,338,901 5,264,128
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 4,589,132 $ 5,743,865